XB-033

N/A

Report date: 2024/05/13 16:10:55

Base Information

Drug NameXB-033
Drug Alias NameIL13Rα2-TOPOi ADC(Exelixis)XB-033
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-IL13RA2DNA topoisomerase inhibitors
TargetsInterleukin-13 receptor subunit alpha-2DNA topoisomerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesExelixis Inc
China Registration ClassN/A

Develop Information

Active CompaniesExelixis Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A